Oliver v. Greenwell

CourtDistrict Court, E.D. Missouri
DecidedFebruary 6, 2023
Docket1:19-cv-00137
StatusUnknown

This text of Oliver v. Greenwell (Oliver v. Greenwell) is published on Counsel Stack Legal Research, covering District Court, E.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Oliver v. Greenwell, (E.D. Mo. 2023).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI SOUTHEASTERN DIVISION

ANNIE LEE OLIVER, et al., ) ) Plaintiffs, ) ) Case No. 1:19 CV 137 ACL vs. ) ) TOMMY GREENWELL, et al., ) ) Defendants. )

MEMORANDUM AND ORDER This matter is before the Court on Plaintiffs’ Second Motion to Compel and/or Motion for Sanctions. (Doc. 93.) The motion is fully briefed and ready for disposition. As an introductory matter, the undersigned notes that this case is still in the discovery phase. Discovery rules are “broadly and liberally construed in order to serve the purpose of discovery,” which is to “provide the parties with information essential to the proper litigation of all relevant facts, to eliminate surprise, and to promote settlement.” Roberts v. Prime Transp. Inc., No. 1:09-CV-46 LMB, 2009 WL 2913917, at *1 (E.D. Mo. Sept. 4, 2009) (internal quotations omitted); see also Mabey v. United States, 999 F.2d 1252, 1254 (8th Cir. 1993) (Discovery is “meant to insure...parties can obtain ‘[m]utual knowledge of all the relevant facts gathered by both parties.’”) (quoting Greyhound Lines, Inc. v. Miller, 402 F.2d 134, 143 (8th Cir. 1968)). A. Background The basis for Plaintiffs’ Second Motion to Compel is that Defendant Advanced Correctional Healthcare’s (“ACH’s”) corporate deponent failed to comply with the Court’s instructions. On September 9, 2022, this Court denied ACH’s request for a Protective Order to prevent the deposition of its corporate designee and instructed ACH to participate. The first deposition of ACH’s corporate deponent, Dr. Jillian Bresnahan, took place on September 13, 2022; and the doctor was not sufficiently prepared to participate in the

deposition. Based on the clear failure of the corporate deponent to answer questions regarding topic areas defined by the Court, leave to take a second deposition was granted. In addition, a sanction was ordered--half of the cost of the first deposition--due to the corporate deponent’s non-compliance with the Court’s instructions. Due to the lack of preparation and/or cooperation, or a combination of the two, in the first deposition, the Court set forth more particular instructions about the topic areas for which the corporate deponent needed to prepare for the second deposition.

A status conference was held with counsel of record before the second deposition on November 7, 2022. The Court commented that based on her prior performance, Dr. Bresnahan may not be best suited to address the remaining questions in the second deposition of the corporate designee. Defense counsel agreed. (Doc. 87, FTR Gold Recording at 4:26 p.m.) Discussion was then held regarding scheduling and deadlines. Dr. Bresnahan was ultimately the corporate deponent who appeared at the second deposition on December 13,

2022. As set out in the Court’s Order, corporations must “prepare [their corporate designees] in order that they can answer fully, completely, and unevasively, the questions posed . . . as to the relevant subject matters.” Wilson v. Lakner, 228 F.R.D. 524, 528 (D. Md. 2005) (quoting Mitsui & Co. v. Puerto Rico Water Res. Auth., 93 F.R.D. 62, 67 (D.P.R. 1981)). While absolute perfection in preparation is not required, courts require corporations to make a “good faith effort” to collect and review all relevant information, and to “interview employees with personal knowledge just as a corporate party is expected to do in answering interrogatories.” Wilson, 228 F.R.D. at 528-29 (Emphasis supplied). An unprepared designee is tantamount to a failure to appear for a deposition. Crawford v. Franklin Credit

Mgmt. Corp., 261 F.R.D. 34, 38-39 (S.D. N.Y. 2009). B. Plaintiffs’ Second Motion to Compel/ for Sanctions

Despite the clear directives articulated by the Court, the corporate deponent failed to effectively participate in the second deposition, which was held on December 13, 2022. In brief, the Court instructed Defendant ACH to be prepared to answer questions regarding several areas, including “Other Inmate Deaths/Allegations of Deliberate Indifference,” as well as “Policies, Procedures, and Training.” The Court will discuss these topics in turn. 1. Other Inmate Deaths/Allegations of Deliberate Indifference

The Court articulated instructions about the litigation matters the corporate deponent needed to be prepared to answer. The subject matter was specifically described, as follows:

1. Insofar as Defendant ACH has acknowledged that information regarding inmate deaths and claims of deliberate indifference to medical needs that have occurred at ACH facilities is available to them, the corporate designee must be prepared to testify about those claims for the timeframe between January 1, 2013, and December 31, 2017, as well as information concerning the specific incidents within the Pemiscot County Jail that are listed in paragraph 52 of the Second Amended Complaint.1

1 Upon review of the pending Motion, it is apparent that Defendant ACH did not enter into a contract with Pemiscot County Jail (PCJ) until September 29, 2015, which was after the deaths of Hamm and Robinson at the PCJ. (Doc. 95-1 at 21.) That said, whether ACH provided any advice to PCJ regarding the deaths of Robinson and Hamm is unclear from the present record before the Court. Dr. Bresnahan’s testimony revealed that ACH does not keep records regarding what, if any, advice ACH may have provided to PCJ regarding the deaths of Robinson and Hamm. In any event, Dr. Bresnahan, as 2. Information concerning “all incidents (whether suit was filed or not), between January 1, 2013, and December 31, 2017, where an individual under the care and treatment of Advanced Correctional Healthcare, Inc. died while in custody.” (Doc. 71-1 at 6, Topic 7) (alterations noted in bold). The topic excludes any protected identifying health information of an inmate, as well as deaths resulting from State-imposed execution, motor vehicle accidents, and attacks by another inmate wherein the deceased was pronounced dead prior to any employee or agent of ACH being notified.

3. “[A]ll other incidents (whether suit was filed or not), between January 1, 2013, and December 31, 2017, where an allegation of deliberate indifference to medical needs has been made against Advanced Correctional Healthcare, Inc.” (Doc. 71-1 at 6, Topic 8) (alterations noted in bold). It excludes protected identifying health information of an inmate but includes specific allegations regarding the circumstances in which deliberate indifference was alleged in an unprotected pleading against ACH in a lawsuit.

(Doc. 89 at 5-6.) Together, Dr. Bresnahan and her attorney dangled information regarding ACH’s deliberate indifference and death-related litigation and non-litigation history at the fingertips of Plaintiffs’ counsel, however, refused disclosure of the document referenced by Dr. Bresnahan during the deposition based on attorney work-product privilege. In the Motion to Compel or for Sanctions, Plaintiffs seek to compel production of all the documents Dr. Bresnahan utilized during the deposition to answer questions. ACH opposes the production of the documents, as protected by the attorney work-product privilege. Federal Rule of Civil Procedure 26(b)(3) provides, in pertinent part, that:

the corporate deponent, had an obligation to address queries concerning “information regarding ACH’s investigation or review of the efficacy of its policies, procedures, protocol training and/or rules regarding inmate medical treatment, evaluation, and/or care related to the deaths of Robinson and Hamm.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Greyhound Lines, Inc., a Corporation v. Delta Miller
402 F.2d 134 (Eighth Circuit, 1968)
Janice Mawby v. United States
999 F.2d 1252 (Eighth Circuit, 1993)
Wilson v. Lakner
228 F.R.D. 524 (D. Maryland, 2005)
Crawford v. Franklin Credit Management Corp.
261 F.R.D. 34 (S.D. New York, 2009)
Sanofi-Aventis v. Sandoz, Inc.
272 F.R.D. 391 (D. New Jersey, 2011)
Sporck v. Peil
759 F.2d 312 (Third Circuit, 1985)
Shelton v. American Motors Corp.
805 F.2d 1323 (Eighth Circuit, 1986)
United States v. Taylor
166 F.R.D. 356 (M.D. North Carolina, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Oliver v. Greenwell, Counsel Stack Legal Research, https://law.counselstack.com/opinion/oliver-v-greenwell-moed-2023.